InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers...
Full Year 2025 vs. Full Year 2024: Seventh Consecutive Year of Record Net Revenues: $143.4 million, Up 6% Net Income...
Investor Conference Call to be held 9:00 a.m. Eastern Time
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers...
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers...
Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25%...
Investor Conference Call to be held 9:00 a.m. Eastern Time
Roth MKM analyst Kyle Bauser reiterated a Buy rating on InfuSystem Holdings today and set a price target of $13.00. The company’s shares closed last Friday at $9.23.Elevate Your Investing Strategy: Take...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers...